| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |